Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus A Ruegg

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2005
Organization of synaptic myonuclei by Syne proteins and their role during the formation of the nerve-muscle synapseMarkus A Ruegg
News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society|June 8, 2001
The Role of Dystroglycan and Its Ligands in Physiology and DiseaseThomas Meier, Markus A. Ruegg
Nature Reviews. Molecular Cell Biology|April 3, 2003
New insights into the roles of agrinGabriela Bezakova, Markus A Ruegg
Trends in Biochemical Sciences|July 19, 2005
Structural and functional diversity generated by alternative mRNA splicingJörg Stetefeld, Markus A Ruegg
Current Opinion in Pharmacology|February 28, 2012
Signaling and aging at the neuromuscular synapse: lessons learnt from neuromuscular diseasesAnna Rostedt Punga, Markus A Ruegg
Skeletal Muscle|September 5, 2012
Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A)Sarina Meinen, Shuo Lin, Markus A Ruegg
EMBO Reports|January 30, 2004
Inhibition of synapse assembly in mammalian muscle in vivo by RNA interferenceXian Chu Kong, Patrizia Barzaghi, Markus A Ruegg
Neuromuscular Disorders : NMD|June 12, 2003
Expression of mouse agrin in normal, denervated and dystrophic muscleAlexander Eusebio, Filippo Oliveri, Patrizia Barzaghi, et al.
Frontiers in Molecular Neuroscience|December 6, 2021
Editorial: Current Insights Into LAMA2 DiseaseStefano C Previtali, Ronald D Cohn, Markus A Ruegg
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 1, 2005
Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient miceC Florian Bentzinger, Patrizia Barzaghi, Shuo Lin, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2005
Organization of synaptic myonuclei by Syne proteins and their role during the formation of the nerve-muscle synapseMarkus A Ruegg
News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society|June 8, 2001
The Role of Dystroglycan and Its Ligands in Physiology and DiseaseThomas Meier, Markus A. Ruegg
Nature Reviews. Molecular Cell Biology|April 3, 2003
New insights into the roles of agrinGabriela Bezakova, Markus A Ruegg
Trends in Biochemical Sciences|July 19, 2005
Structural and functional diversity generated by alternative mRNA splicingJörg Stetefeld, Markus A Ruegg
Current Opinion in Pharmacology|February 28, 2012
Signaling and aging at the neuromuscular synapse: lessons learnt from neuromuscular diseasesAnna Rostedt Punga, Markus A Ruegg
Skeletal Muscle|September 5, 2012
Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A)Sarina Meinen, Shuo Lin, Markus A Ruegg
EMBO Reports|January 30, 2004
Inhibition of synapse assembly in mammalian muscle in vivo by RNA interferenceXian Chu Kong, Patrizia Barzaghi, Markus A Ruegg
Neuromuscular Disorders : NMD|June 12, 2003
Expression of mouse agrin in normal, denervated and dystrophic muscleAlexander Eusebio, Filippo Oliveri, Patrizia Barzaghi, et al.
Frontiers in Molecular Neuroscience|December 6, 2021
Editorial: Current Insights Into LAMA2 DiseaseStefano C Previtali, Ronald D Cohn, Markus A Ruegg
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 1, 2005
Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient miceC Florian Bentzinger, Patrizia Barzaghi, Shuo Lin, et al.
Pageof 4